Early outcomes of tocilizumab in adults hospitalized with severe COVID-19 - The Vall d’Hebron COVID-19 prospective cohort study

Adrián Sánchez-Montalvá; Júlia Sellarés-Nadal; Juan Espinosa-Pereiro; Nuria Fernández-Hidalgo; Santiago Pérez-Hoyos; Fernando Salvador; Xavier Durà; Marta Miarons; Andrés Antón; Simeón Eremiev-Eremiev; Abiu Sempere-González; Arnau Monforte-Pallarés; Pau Bosch-Nicolau; Salvador Augustin; Júlia Sampol; Alfredo Guillén-del-Castillo; Benito Almirante

doi:10.1101/2020.05.07.20094599

Early outcomes of tocilizumab in adults hospitalized with severe COVID-19 - The Vall d’Hebron COVID-19 prospective cohort study

View ORCID ProfileAdrián Sánchez-Montalvá, Júlia Sellarés-Nadal, View ORCID ProfileJuan Espinosa-Pereiro, View ORCID ProfileNuria Fernández-Hidalgo, View ORCID ProfileSantiago Pérez-Hoyos, Fernando Salvador, Xavier Durà, Marta Miarons, View ORCID ProfileAndrés Antón, Simeón Eremiev-Eremiev, Abiu Sempere-González, Arnau Monforte-Pallarés, View ORCID ProfilePau Bosch-Nicolau, Salvador Augustin, Júlia Sampol, Alfredo Guillén-del-Castillo, Benito Almirante

doi: https://doi.org/10.1101/2020.05.07.20094599

Adrián Sánchez-Montalvá

1Infectious Diseases Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain

8International Health Program of the Catalan Institut of Health (PROSICS), Barcelona, Spain

9Tropical Medicine Spanish Research Network (RICET), Madrid, Spain

MD, PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Adrián Sánchez-Montalvá
For correspondence: adsanche@vhebron.net

Júlia Sellarés-Nadal

1Infectious Diseases Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Juan Espinosa-Pereiro

1Infectious Diseases Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain

8International Health Program of the Catalan Institut of Health (PROSICS), Barcelona, Spain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Juan Espinosa-Pereiro

Nuria Fernández-Hidalgo

1Infectious Diseases Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain

10Infectous Diseases Spanish Research Network (REIPI), Madrid, Spain

MD, PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Nuria Fernández-Hidalgo

Santiago Pérez-Hoyos

2Statistic Unit, Vall d’Hebron Institute of Research, Barcelona, Spain

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Santiago Pérez-Hoyos

Fernando Salvador

1Infectious Diseases Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain

8International Health Program of the Catalan Institut of Health (PROSICS), Barcelona, Spain

9Tropical Medicine Spanish Research Network (RICET), Madrid, Spain

MD, PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Xavier Durà

1Infectious Diseases Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marta Miarons

3Pharmacy Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain

Pharm D, PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Andrés Antón

4Microbiology Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain

10Infectous Diseases Spanish Research Network (REIPI), Madrid, Spain

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Andrés Antón

Simeón Eremiev-Eremiev

1Infectious Diseases Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Abiu Sempere-González

1Infectious Diseases Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Arnau Monforte-Pallarés

1Infectious Diseases Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Pau Bosch-Nicolau

1Infectious Diseases Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Pau Bosch-Nicolau

Salvador Augustin

5Hepatology Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain

MD, PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Júlia Sampol

6Pneumology Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alfredo Guillén-del-Castillo

7Internal Medicine Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain

MD, PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Benito Almirante

1Infectious Diseases Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain

10Infectous Diseases Spanish Research Network (REIPI), Madrid, Spain

MD, PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Abstract
Full Text
Info/History
Metrics
Supplementary material
Data/Code
Preview PDF

Data Availability

Unidentified dataset can be made available upon request to the corresponding author (ASM) after publication of the manuscript.

View the discussion thread.

PreviousNext

Posted July 10, 2020.

Download PDF

Supplementary Material

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Early outcomes of tocilizumab in adults hospitalized with severe COVID-19 - The Vall d’Hebron COVID-19 prospective cohort study

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Early outcomes of tocilizumab in adults hospitalized with severe COVID-19 - The Vall d’Hebron COVID-19 prospective cohort study

Adrián Sánchez-Montalvá, Júlia Sellarés-Nadal, Juan Espinosa-Pereiro, Nuria Fernández-Hidalgo, Santiago Pérez-Hoyos, Fernando Salvador, Xavier Durà, Marta Miarons, Andrés Antón, Simeón Eremiev-Eremiev, Abiu Sempere-González, Arnau Monforte-Pallarés, Pau Bosch-Nicolau, Salvador Augustin, Júlia Sampol, Alfredo Guillén-del-Castillo, Benito Almirante

medRxiv 2020.05.07.20094599; doi: https://doi.org/10.1101/2020.05.07.20094599

Share This Article: